Trial intelligence / Profile preview

Acamprosate vs Naltrexone in Protracted Abstinence

NCT00656630Phase 2Completed

Sponsor
Scripps Research
Start
Dec 2007
Primary completion
Jan 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of acamprosate, naltrexone in alcohol dependence, sponsored by Scripps Research. Started Dec 2007; status: completed.

02

Drugs

acamprosatenaltrexone
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT00656630.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00656630.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call